HomeCompareJOET vs JNJ

JOET vs JNJ: Dividend Comparison 2026

JOET yields 0.71% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 JOET wins by $646.00 in total portfolio value
10 years
JOET
JOET
● Live price
0.71%
Share price
$38.98
Annual div
$0.27
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.7K
Annual income
$73.83
Full JOET calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — JOET vs JNJ

📍 JOET pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodJOETJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, JOET + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
JOET pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

JOET
Annual income on $10K today (after 15% tax)
$59.94/yr
After 10yr DRIP, annual income (after tax)
$62.76/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, JNJ beats the other by $640.86/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of JOET + JNJ for your $10,000?

JOET: 50%JNJ: 50%
100% JNJ50/50100% JOET
Portfolio after 10yr
$20.3K
Annual income
$450.80/yr
Blended yield
2.22%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

JOET
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

JOET buys
0
JNJ buys
0
No recent congressional trades found for JOET or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricJOETJNJ
Forward yield0.71%3.36%
Annual dividend / share$0.27$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$20.7K$20.0K
Annual income after 10y$73.83$827.78
Total dividends collected$723.00$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: JOET vs JNJ ($10,000, DRIP)

YearJOET PortfolioJOET Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$10,771$70.52$10,676$355.77+$95.00JOET
2$11,595$70.99$11,407$389.39+$188.00JOET
3$12,479$71.42$12,198$426.53+$281.00JOET
4$13,424$71.83$13,056$467.62+$368.00JOET
5$14,436$72.22$13,987$513.12+$449.00JOET
6$15,519$72.58$14,998$563.56+$521.00JOET
7$16,678$72.92$16,098$619.52+$580.00JOET
8$17,919$73.24$17,295$681.69+$624.00JOET
9$19,247$73.55$18,599$750.82+$648.00JOET
10$20,668$73.83$20,022$827.78+$646.00JOET

JOET vs JNJ: Complete Analysis 2026

JOETStock

The Fund strives to deliver exposure to U.S.-listed large-cap companies that combine strong quality fundamentals with positive momentum technical trends. The Fund seeks investment results that correspond, before fees and expenses, to the performance of the Terranova U.S. Quality Momentum Index. Joe Terranova , Senior Managing Director and Chief Market Strategist for Virtus Investment Partners, created and developed the Terranova U.S. Quality Momentum Index, whose methodology reflects the investing principles he has utilized to assess markets throughout his 30+ year career on Wall Street. Indxx, LLC is the index provider and calculation agent. The portfolio managers are affiliated with Virtus Investment Advisers, LLC, the Fund's adviser.

Full JOET Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this JOET vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

JOET vs SCHDJOET vs JEPIJOET vs OJOET vs KOJOET vs MAINJOET vs ABBVJOET vs MRKJOET vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.